Evaluation of Serum Vascular Adhesion Protein-1 As a Potential Biomarker in Thyroid Cancer

Overview

Journal Int J Endocrinol

Publisher Wiley

Specialty Endocrinology

Date 2016 Jul 23

PMID 27446209

Citations 4

Authors

ZhiGang Hu

Pengxin Zhao

Kaili Zhang

Leilei Zang

Haiying Liao

Weiyuan Ma

Affiliations

Soon will be listed here.

Abstract

Vascular adhesion protein-1 (VAP-1) is a glycoprotein that mediates tissue-selective lymphocyte adhesion. The prognostic value of VAP-1 has been determined in gastric cancer. The aim of this study was to evaluate the changes and the predictive value of serum VAP-1 in patients with thyroid cancer. A total of 126 patients with thyroid nodules and 53 healthy controls participated in this study. The patients were further divided into subgroup 1 (69 cases with benign thyroid nodules) and subgroup 2 (57 cases with thyroid cancer). Serum VAP-1 was measured by time-resolved immunofluorometric assay. Diagnostic value of presurgical VAP-1 for thyroid cancer was conducted by receiver operating characteristic (ROC) curves. Serum levels of VAP-1 were significantly lower in thyroid cancer group than in healthy control and benign thyroid nodule groups. VAP-1 concentrations negatively correlated with serum thyroglobulin (Tg) levels in thyroid cancer patients (r = -0.81; p < 0.001). The optimum cut-off value of VAP-1 was 456.6 ng/mL with a 77.4% specificity and 66.7% sensitivity for thyroid cancer diagnosis. Serum VAP-1 decreased in thyroid cancer patients and VAP-1 could be a potential useful adjunct biomarker in the diagnosis of thyroid cancer.

Citing Articles

Serum Vascular Adhesion Protein-1 and Endothelial Dysfunction in Hepatic Cirrhosis: Searching for New Prognostic Markers.

Fasolato S, Bonaiuto E, Rossetto M, Vanzani P, Ceccato F, Vittadello F Int J Mol Sci. 2024; 25(13).

PMID: 39000418 PMC: 11242677. DOI: 10.3390/ijms25137309.

Complement C4-A and Plasminogen as Potential Biomarkers for Prediction of Papillary Thyroid Carcinoma.

Wang Y, Zhou S, Wang D, Wei T, Zhu J, Li Z Front Endocrinol (Lausanne). 2021; 12:737638.

PMID: 34803909 PMC: 8603925. DOI: 10.3389/fendo.2021.737638.

The Blood Biomarkers of Thyroid Cancer.

Wang W, Chang J, Jia B, Liu J Cancer Manag Res. 2020; 12:5431-5438.

PMID: 32753960 PMC: 7351621. DOI: 10.2147/CMAR.S261170.

Vascular Adhesion Protein-1: A Cell Surface Amine Oxidase in Translation.

Salmi M, Jalkanen S Antioxid Redox Signal. 2017; 30(3):314-332.

PMID: 29065711 PMC: 6306676. DOI: 10.1089/ars.2017.7418.

References

Toiyama Y, Miki C, Inoue Y, Kawamoto A, Kusunoki M . Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis. J Surg Oncol. 2009; 99(6):368-72. DOI: 10.1002/jso.21246. View

Robenshtok E, Grewal R, Fish S, Sabra M, Tuttle R . A low postoperative nonstimulated serum thyroglobulin level does not exclude the presence of radioactive iodine avid metastatic foci in intermediate-risk differentiated thyroid cancer patients. Thyroid. 2012; 23(4):436-42. DOI: 10.1089/thy.2012.0352. View

Ward S, Weston C, Shepherd E, Hejmadi R, Ismail T, Adams D . Evaluation of serum and tissue levels of VAP-1 in colorectal cancer. BMC Cancer. 2016; 16:154. PMC: 4766640. DOI: 10.1186/s12885-016-2183-7. View

Liu Y, Morreau H, Kievit J, Romijn J, Carrasco N, Smit J . Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of.... Eur J Endocrinol. 2008; 158(3):375-84. DOI: 10.1530/EJE-07-0492. View

Sands N, Karls S, Rivera J, Tamilia M, Hier M, Black M . Preoperative serum thyroglobulin as an adjunct to fine-needle aspiration in predicting well-differentiated thyroid cancer. J Otolaryngol Head Neck Surg. 2010; 39(6):669-73. View

Li Y, Hung J, Yu T, Liou J, Wei J, Kao H . Serum vascular adhesion protein-1 predicts all-cause mortality and cancer-related mortality in subjects with colorectal cancer. Clin Chim Acta. 2013; 428:51-6. DOI: 10.1016/j.cca.2013.10.024. View

Wu Y, Yue X, Shen W, Du Y, Yuan Y, Tao X . Diagnostic value of diffusion-weighted MR imaging in thyroid disease: application in differentiating benign from malignant disease. BMC Med Imaging. 2013; 13:23. PMC: 3750353. DOI: 10.1186/1471-2342-13-23. View

Stolen C, Yegutkin G, Kurkijarvi R, Bono P, Alitalo K, Jalkanen S . Origins of serum semicarbazide-sensitive amine oxidase. Circ Res. 2004; 95(1):50-7. DOI: 10.1161/01.RES.0000134630.68877.2F. View

Lee E, Chung K, Min H, Kim T, Kim T, Ryu J . Preoperative serum thyroglobulin as a useful predictive marker to differentiate follicular thyroid cancer from benign nodules in indeterminate nodules. J Korean Med Sci. 2012; 27(9):1014-8. PMC: 3429817. DOI: 10.3346/jkms.2012.27.9.1014. View

10.

Barroeta J, Baloch Z, Lal P, Pasha T, Zhang P, Livolsi V . Diagnostic value of differential expression of CK19, Galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis. Endocr Pathol. 2007; 17(3):225-34. DOI: 10.1385/ep:17:3:225. View

11.

Kunavisarut T . Diagnostic biomarkers of differentiated thyroid cancer. Endocrine. 2013; 44(3):616-22. DOI: 10.1007/s12020-013-9974-2. View

12.

Smith D, Salmi M, Bono P, Hellman J, Leu T, Jalkanen S . Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J Exp Med. 1998; 188(1):17-27. PMC: 2525535. DOI: 10.1084/jem.188.1.17. View

13.

Scheffler P, Forest V, Leboeuf R, Florea A, Tamilia M, Sands N . Serum thyroglobulin improves the sensitivity of the McGill Thyroid Nodule Score for well-differentiated thyroid cancer. Thyroid. 2013; 24(5):852-7. DOI: 10.1089/thy.2013.0191. View

14.

Cooper D, Doherty G, Haugen B, Hauger B, Kloos R, Lee S . Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009; 19(11):1167-214. DOI: 10.1089/thy.2009.0110. View

15.

Jensen M, Chacon M, Sattin J, Aleu A, Lyden P . The promise and potential pitfalls of serum biomarkers for ischemic stroke and transient ischemic attack. Neurologist. 2008; 14(4):243-6. PMC: 2670566. DOI: 10.1097/NRL.0b013e31815a9945. View

16.

Shi J, Xu Y, Pan Q, Sui G, Zhou J, Wang H . The value of combined application of ultrasound-guided fine needle aspiration cytology and thyroglobulin measurement for the diagnosis of cervical lymph node metastases from thyroid cancer. Pak J Med Sci. 2015; 31(5):1152-5. PMC: 4641273. DOI: 10.12669/pjms.315.6726. View

17.

Gokturk C, Nilsson J, Nordquist J, Kristensson M, Svensson K, Soderberg C . Overexpression of semicarbazide-sensitive amine oxidase in smooth muscle cells leads to an abnormal structure of the aortic elastic laminas. Am J Pathol. 2003; 163(5):1921-8. PMC: 1892430. DOI: 10.1016/S0002-9440(10)63550-X. View

18.

Ito Y, Nikiforov Y, Schlumberger M, Vigneri R . Increasing incidence of thyroid cancer: controversies explored. Nat Rev Endocrinol. 2013; 9(3):178-84. DOI: 10.1038/nrendo.2012.257. View

19.

Li H, Jiang Y, Chang T, Wei J, Lin M, Lin C . Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes. Diabetes. 2011; 60(3):993-9. PMC: 3046860. DOI: 10.2337/db10-0607. View

20.

Chen H, Huang H, Lin Y, Chang K, Kuo W, Hwa H . Comparison and identification of estrogen-receptor related gene expression profiles in breast cancer of different ethnic origins. Breast Cancer (Auckl). 2011; 1:35-49. PMC: 3091396. DOI: 10.4137/bcbcr.s626. View